Part 160. Arkansas State Board of Pharmacy Rules

158 sections in this chapter.

158 sectionsFiltered byCh 17.30.A.160

17.30.A.160-160-1704 17 CAR § 160-1704. Categories for permits
2.4K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-1705 17 CAR § 160-1705. Pharmacist present when medication provided
0.6K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-1706 17 CAR § 160-1706. Rule regarding charitable clinic pharmacies procuring and dispensing donated prescription medication
11.5K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-1801 17 CAR § 160-1801. Definition
1.1K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-1802 17 CAR § 160-1802. General requirements
0.6K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-1803 17 CAR § 160-1803. Responsibilities
10.0K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-1804 17 CAR § 160-1804. Emergency kits for long-term care and other approved institutional facilities
6.1K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-1805 17 CAR § 160-1805. Drug categories for emergency kits in long-term care facilities
2.2K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-1806 17 CAR § 160-1806. Drug categories for emergency kits in hospice care facilities
1.6K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-1807 17 CAR § 160-1807. Drug categories for emergency kits in crisis stabilization units
1.8K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-1901 17 CAR § 160-1901. Procedures for disciplinary action
1.7K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2001 17 CAR § 160-2001. Definitions
2.2K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs6CCB3C5A{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:bold;font-style:normal;} .cs827F4F4D{color:#000000;background-color:transparent;font-fam…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2002 17 CAR § 160-2002. Facsimile (fax) prescription drug order
6.6K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2003 17 CAR § 160-2003. Prescription transfers
3.2K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2004 17 CAR § 160-2004. Signing prescriptions
0.8K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2005 17 CAR § 160-2005. Secret codes prohibited
1.1K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2006 17 CAR § 160-2006. Maintenance and retention of drug records
1.4K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2007 17 CAR § 160-2007. Generic substitution
1.5K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2008 17 CAR § 160-2008. Dispensing generically equivalent drug product
1.3K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs6CCB3C5A{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:bold;font-style:normal;} .cs827F4F4D{color:#000000;background-color:transparent;font-fam…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2009 17 CAR § 160-2009. Electronic prescription processing and patient confidentiality
7.5K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-201 17 CAR § 160-201. Changes in employment
1.1K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2010 17 CAR § 160-2010. Proper practitioner-patient relationship
1.4K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2011 17 CAR § 160-2011. Therapeutic substitution
2.8K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-202 17 CAR § 160-202. Replacement of pharmacist’s certificate
0.7K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-203 17 CAR § 160-203. Practice after inactivity when reciprocating or reinstating a license
1.8K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2101 17 CAR § 160-2101. Controlled substances approved by the Food and Drug Administration
1.2K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2102 17 CAR § 160-2102. Drug products must have a new drug application or an abbreviated new drug application
2.6K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2201 17 CAR § 160-2201. Standards for compounding and dispensing sterile products
22.4K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2202 17 CAR § 160-2202. Good compounding practices
19.1K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2301 17 CAR § 160-2301. Drug samples
4.4K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2401 17 CAR § 160-2401. Schedule II prescription drugs
3.2K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2402 17 CAR § 160-2402. Partial filling of a Schedule II prescription
3.1K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2403 17 CAR § 160-2403. Computer records for partial filling
2.0K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2404 17 CAR § 160-2404. Time limit on a new Schedule II prescription
0.9K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2405 17 CAR § 160-2405. Theft or loss of controlled drugs
1.1K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2406 17 CAR § 160-2406. Schedule V — Exempt products and pharmacist-authorized drugs
4.6K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2407 17 CAR § 160-2407. Schedule V — Exempt narcotics
2.7K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2408 17 CAR § 160-2408. Schedule V — Ephedrine, pseudoephedrine, or phenylpropanolamine
4.2K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2501 17 CAR § 160-2501. Prescription Delivery Standards
1.5K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2601 17 CAR § 160-2601. Definitions
8.0K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2602 17 CAR § 160-2602. Sales permit required
0.7K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2603 17 CAR § 160-2603. Wholesale distributors, third-party logistics providers, manufacturers, and outsourcing facilities — Permit required
5.2K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2604 17 CAR § 160-2604. Shipment to certain licensed professionals
1.5K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2605 17 CAR § 160-2605. Minimum required information for licensure
2.2K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2606 17 CAR § 160-2606. Minimum qualifications
2.2K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2607 17 CAR § 160-2607. Personnel
0.6K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2608 17 CAR § 160-2608. Minimum requirements for the storage and handling of prescription drugs and for the establishment and maintenance of prescription drug distribution records
8.6K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2609 17 CAR § 160-2609. Written policies and procedures
3.0K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2610 17 CAR § 160-2610. Responsible persons
0.7K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗
17.30.A.160-160-2611 17 CAR § 160-2611. Compliance with federal, state, and local laws
1.6K chars
.csEE311CB1{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.65} .cs827F4F4D{color:#000000;background-color:transparent;font-family:Tahoma,Arial;font-size:12pt;font-weight:normal;font-style:normal;} .cs6CCB3C5A{color:#000000;background-color:transparent;font-f…
17.30.A.160Open chapter PDF ↗